Altre lingue Entheon Biomedical Corp.

Azioni

ENBI

CA29383X2023

Tempo differito Canadian Securities Exchange Altri mercati azionari 15:30:00 30/04/2024			Variaz. 5gg	Var. 1 gen.
0,165 ^CAD	-.--%		-17,50%	+65,00%

26/03	Entheon Biomedical Corp. riporta i risultati degli utili per l'intero anno conclusosi il 30 novembre 2023	CI
2023	Entheon Biomedical Corp. Riporta i risultati degli utili per il terzo trimestre e i nove mesi conclusi il 31 agosto 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Entheon Biomedical Corp. Reports Earnings Results for the First Quarter Ended February 29, 2024	29/04
Entheon Biomedical Corp. announced that it has received CAD 0.1475 million in funding	18/04
Entheon Biomedical Corp. announced that it expects to receive CAD 0.1475 million in funding	11/04
Entheon Biomedical Corp. Reports Earnings Results for the Full Year Ended November 30, 2023	26/03
Entheon Biomedical Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2023	26/10/23
Entheon Biomedical Corp. Announces Termination of Andrew Hegle as Chief Science Officer	01/08/23
Entheon Biomedical Corp. Reports Earnings Results for the Second Quarter and Six Months Ended May 31, 2023	27/07/23
Heading Health Inc. announced that it has received $4.5 million in funding from a group of investors	29/06/23
Entheon Biomedical Corp. Reports Earnings Results for the First Quarter Ended February 28, 2023	29/04/23
Entheon Biomedical Corp. Announces Termination of Consulting Agreement with Cybin	28/04/23
Entheon Biomedical Corp. Auditor Raises 'Going Concern' Doubt	23/03/23
Entheon Biomedical Corp. Announces Resignation of Ruth Chun as Director	02/03/23
Entheon Biomedical Corp. Announces CFO Changes	06/01/23
Entheon Biomedical Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2022	31/10/22
Entheon Biomedical Corp. Closes Patient Enrolment in its Clinical Research Study EBIQ-101	05/10/22
Entheon Biomedical : CFO Certification	27/07/22
Entheon Biomedical : CEO Certification	27/07/22
Entheon Biomedical : Quarterly Report	27/07/22
Entheon Biomedical Corp. Reports Earnings Results for the Second Quarter and Six Months Ended May 31, 2022	27/07/22
Entheon Biomedical Corp. cancelled the transaction announced on April 5, 2022	07/06/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Entheon Biomedical Corp.

Azioni

ENBI

CA29383X2023

Altre lingue

Filtri